Parallel session 15.00 - 16.30
Partnership Strategies towards Affordable and Accessible Healthcare
Debate around the price of medicines is intense. The overall societal issue of how to keep healthcare affordable sometimes seems to focus solely on the costs of new drugs. Innovation in developing new therapies and personalized medicine is often regarded as a driving force behind even higher prices. The end goal, namely finding ways to treat a certain disease and provide hope for patients, seems sometimes completely overlooked in the discussion.
On the bright side, various initiatives and partnerships have been established over the past couple of years that directly or indirectly aim to find new (business) models that balance innovation and costs while developing new medicines.
This session will start with an overview of the challenge at hand, focusing on medicines. Four partnerships that are active in various stages of the drug development pipeline will pitch their approach. A discussion guided by propositions will conclude the session.
Chair: Michel Rudolphie, Board member Lygature and former director of the Dutch Cancer Society
- Overview of the challenge: Philip Idenburg (founder and director BeBright)
- European Lead Factory:
Jon de Vlieger (Business Development Director @Lygature)
- FAIR Medicine:
Hans Büller (founder FAIR Medicine)
- Oncode Institute:
Irene Kanter-Schlifke (Program Manager Oncode @Lygature)
- Utrecht Center for Affordable Biotherapeutics:
Netty Dorrestijn (General Manager UCAB)